EU drug agency recommends approving COVID-19 treatment
THE HAGUE, Netherlands (AP) — The European Union’s drugs agency has recommended approving the use of an anti-inflammatory medicine to treat adults hospitalized with severe COVID-19. The European Medicines Agency decision Monday has to be confirmed by the E.U.’s executive commission. It extends the use of the drug RoActemra, made by Swiss pharmaceuticals giant Roche,
Continue Reading